The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders-Reference-Cited by-同舟云学术

The Kinetics of Antidrug Antibodies, Drug Levels, and Clinical Outcomes in Infliximab-Exposed Patients with Immune-Mediated Disorders

Published:2018-11 Issue:6 Volume:6 Page:2065-2072.e2
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Nencini Francesca,Vultaggio Alessandra,Pratesi Sara,Cammelli Daniele,Milla Monica,Fiori Ginevra,Bagnoli Siro,Prignano Francesca,Romagnani Sergio,Maggi Enrico,Matucci Andrea

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference37 articles.

1. Tumor necrosis factor inhibitors: clinical utility in autoimmune diseases;Willrich;Transl Res,2015

2. Optimizing use of tumor necrosis factor inhibitors in the management of immune-mediated inflammatory diseases;Bressler;J Rheumatol Suppl,2010

3. Infliximab: a review of its use in Crohn's disease and rheumatoid arthritis;Siddiqui;Drugs,2005

4. Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis;Van Schouwenburg;Nat Rev Rheumatol,2013

5. Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab;Mitoma;Arthritis Rheum,2008

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is infliximab therapy currently relevant in patients with inflammatory bowel diseases? (review);Koloproktologia;2024-06-21

2. Tannic acid assisted anti-TNF-α nanobody assembly modulating the epithelial barrier dysregulation of allergic rhinitis;Nano Research;2023-04-14

3. Hypersensitivity reactions to biologics in children;Expert Opinion on Biological Therapy;2023-01-02

4. Assessing Immunogenicity of Biologic Drugs in Inflammatory Joint Diseases: Progress Towards Personalized Medicine;BioDrugs;2022-10-31

5. Hypersensitivity Reactions to Monoclonal Antibodies: New Approaches;Current Treatment Options in Allergy;2022-08-18